Neudle.com: Parkinson disease progression

Differential
(Click to cross reference)

adolescent medicine

advances in neurology

adverse drug reaction

affect, flat

akathisia

alcohol, neurologic complications with

aphasia, progressive, primary

apraxia

apraxia, constructional

auditory and vestibular pathways

autoantibodies

autoimmune cerebellar ataxia

autoimmune disease

autonomic cardiovascular reflexes

autonomic dysfunction

axonal degeneration

basal ganglia

basal ganglia, lesion of

basal ganglia, lesion, bilateral

carbon monoxide poisoning

cardiomyopathy

CAT scan, emission, abnormal

cataplexy

cavernous hemangioma

central hypoventilation

cerebellar ataxia, neuropathy and vestibular areflexia syndrome

cerebellar atrophy, primary

cerebellar atrophy, secondary

cerebellar edema

cerebellar lesion

cerebellitis

cerebellum, disease of

cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy

cerebral cortical atrophy

cerebral infarction

cerebrospinal fluid, elevated protein of

cerebrovascular accident

cerebrovascular accident, nonarterial territory

children

chorea

chromosomal abnormality

chromosome 19

cingulate island sign

cirrhosis

climate change

Clinical Pathologic Conference(C.P.C.)

computers, medicine and

contractures, joint

controversies in neurology

corpus callosum, thinning

cortical blindness

cortical infarction

cortical-basal ganglionic degeneration

cough

degenerative diseases of CNS

delay in diagnosis

delusion

dementia

dementia, age at onset

dementia, familial

dementia, frontal lobe type

dementia, frontotemporal

dementia, presenile

dementia, rapidly progressive

depression

developmental milestones, loss of

developmental retardation

dexterity, impaired

diabetes mellitus

diagnostic criteria

differential diagnosis

diplopia

disorientation

distal muscle atrophy

diurnal variation

dopa responsive dystonia

dopamine agonist

drug induced neurologic disorders

encephalitis, episodic

encephalitis, Powassan

encephalitis, viral

encephalopathy

encephalopathy, delayed

encephalopathy, progressive

enzyme, defect

epidemiology of neurology

erectile dysfunction

evidence-based research

executive dysfunction

exome sequencing

eye movement, disorders of

fourth ventricle, compression

frontal behavioral spatial syndrome

frontotemporal dementia, behavioral variant

gait disorder

galactorrhea

gammaglobulin therapy, intravenous

gaze palsy, horizontal

gaze palsy, supranuclear

genetic neurologic disorders

genetic screening

genetic testing

globus pallidus

globus pallidus, lesion of

globus pallidus, lesion of, bilateral

glutamic acid decarboxylase, antibody

grasp reflex

Hallervorden Spatz disease

hallucination

headache

hearing loss

hemangioma, brainstem

hepatolenticular degeneration, non-Wilsonian

hyperammonemic encephalopathy

hypotension, neurologic causes of

hypotension, systemic

hypothyroidism

iatrogenic neurologic disorders

inclusion bodies, intranuclear

incontinence, fecal

inflexibility, mental

insect sting

insomnia

intellectual deficit

intellectual deterioration

intracerebral hemorrhage

iron, brain

Jakob-Creutzfeldt disease

L-dopa

leg spasms, painful

lenticular nucleus, lesion of, bilateral

leukoencephalopathy

level of consciousness, decreased

Lewy body

Lewy body disease, diffuse

malformation, vascular

malformation, vascular, cerebral

marche a petits pas

masked facies

MELAS syndrome

memory, defect of recent

memory, impairment of

meningeal enhancement

meningismus

meningitis

meningoencephalitis

mental status, abnormal

micrographia

miglustat

migratory lesion pattern

mimics

misdiagnosis

mitochondrial disease

movement disorder, drug induced

movement disorder, extrapyramidal

MRI

MRI, abnormal

MRI, contrast enhanced

MRI, diffusion weighted

MRI, eye of tiger sign

MRI, gradient-echo

MRI, high signal intensity of basal ganglia

MRI, negative

MRI, paramagnetic effect

MRI, susceptibility weighted

MRI, T1 weighted high signal foci

multiple system atrophy

neurodegeneration with brain iron accumulation

neuroleptic, atypical

neurologic consultation

neurologic disease

neurologic disease, diagnoses of

neurologic disease, tempo

neurologic examination, focal

neurologic signs

neurologic testing

neuronal intranuclear inclusion disease

neuronopathy

neuronopathy, sensory

neuropathology

neuropathology, brain

neuropathy

neuropathy, sensory

neuroprotective agents

New England

Niemann-Pick disease

numbness, extremity

obsessive-compulsive disorder

ocular motility, disorders of

old age, neurology of

ophthalmoplegia, progressive external

organomegaly

orthostatic hypotension

pain, increased response

Parkinson disease, atypical

Parkinson disease, dementia with

Parkinson disease, diagnosis

Parkinson disease, differential diagnosis of

Parkinson disease, drug induced

Parkinson disease, duration

Parkinson disease, dystonia with

Parkinson disease, etiology of

Parkinson disease, familial

Parkinson disease, heterogeneity of

Parkinson disease, juvenile

Parkinson disease, late onset

Parkinson disease, L-dopa nonresponsive

Parkinson disease, mode of onset

Parkinson disease, nonmotor problems of

Parkinson disease, pathogenesis of

Parkinson disease, prognosis of

Parkinson disease, progression

Parkinson disease, rapid onset

Parkinson disease, rapid progression

Parkinson disease, surgical treatment of

Parkinson disease, treatment of

Parkinson disease, tremor, absence of

Parkinson disease, unilateral

Parkinson disease, young onset

Parkinsonism multiple-system atrophy

Parkinsonism syndrome

Parkinsonism, freezing phenomena in

Parkinsonism-dementia complex

pathology

patient information and support

personality change

Pick bodies

Pick's disease

pleocytosis of cerebrospinal fluid

progressive neurologic disorder

progressive supranuclear palsy

prolactin, elevated

psychiatric problems in neurologic disorders

psychomotor retardation

pyramidal tract dysfunction

recurrent

Red flags

release phenomena

respirations in CNS disease

salivation, excessive

seizure, laughing as manifestation

selective serotonin reuptake inhibitors

serologic testing

shoulder, pain in

sinemet

single photon emission computed tomography

sleep apnea, obstructive

sleep pathology and physiology

smell

SNCA duplication

speech disorder

speech disorder, childhood

stimulation, deep brain

striatonigral degeneration

temporal lobe, atrophy

tick bite

tick-borne encephalitis

toe walking

tonic foot response

treatment of neurologic disorder

tyrosine hydroxylase deficiency

visuospatial disturbance

vocal cord paralysis

walking

walking frame

walking, difficulty with

weakness

weakness, progressive

weight loss

wheelchair

white matter disease

whole genome sequencing

wide based gait

Wolff-Parkinson-White syndrome

word-finding difficulty

workup

Showing articles 650 to 700 of 2059 << Previous Next >>

Gout and Risk of Parkinson Disease: A Prospective Study
Neurol 69:1696-1700, Alonso,A.,et al, 2007

Hemiparkinsonism-hemiatrophy Syndrome
Neurol 69:1585-1594, Wijemanne,S. &Jankovic,J., 2007

Sniffing Out Parkinson Disease: Can Olfactory Testing Differentiate Parkinsonian Disorders?
Neurologist 13:382-385, McKinnon,J.H.,et al, 2007

Compulsive Singing: Another Aspect of Punding in Parkinsons Disease
Ann Neurol 62:525-528, Bonvin,C.,et al, 2007

Parkinson Disease, 10 Years After Its Genetic Revolution: Multiple Clues to a Complex Disorder
Neurol 69:2093-2104, Klein,C. &Schlossmacher,M.G., 2007

GPi Deep Brain Stimulation for Tourette Syndrome Improves Tics and Psychiatric Comorbidities
Neurol 68:159-161, Shahed,J.,et al, 2007

Valvular Heart Disease and the Use of Dopamine Agonists for Parkinsons Disease
NEJM 356:39-46, Zanettini,R.,et al, 2007

Dopamine Agonists and the Risk of Cardiac Valve Regurgitation
NEJM 356:29-38, Schade,R.,et al, 2007

Asymptomatic Hemorrhage After Thrombolysis May Not Be Benign: Prognosis by Hemorrhage Type in the Canadian Alteplase for Stroke Effectiveness Study Registry
Stroke 38:7579, Dzialowski,I.,et al, 2007

Long-term Outcome of Bilateal Pallidal Deep Brain Stimulation for Primary Cervical Dystonia
Neurol 68:457-459, Hung,S.W.,et al, 2007

Long-Term Outcome of Bilateral Pallidal Deep Brain Stimulation for Primary Cervical Dystonia
Neurol 68:457-459, Hung,S.W.,et al, 2007

Randomized, Blind, Controlled Trial of Transdermal Rotigotine in Early Parkinson Disease
Neurol 68:272-276, Watts,R.L.,et al, 2007

Pathologic Gambling in Patients with Restless Legs Syndrome Treated With Dopaminergic Agonists
Neurol 68:301-303, Tippmann-Peikert,M.,et al, 2007

Cardiac Valve Regurgitation With Pergolide Compared With Nonergot Agonsits in Parkinson Disease
Arch Neurol 64:377-380, Dewey,R.B.,Jr, et al, 2007

Neuroimaging of Bilateral Caudate Infarction Manifesting as Parkinsonian Gait Disorder
Conn Med 71:149-150, Finelli,P.F., et al, 2007

Comparison of CT Perfusion and Angiography and MRI in Selecting Stroke Patients for Acute Treatment
Neurol 68:694-697, Wintermark,M.,et al, 2007

Sexual Function in Men and Women With Neurological Disorders
Lancet 369:512-525, Rees,P.M.,et al, 2007

Contrast Extravasatioin on CT Angiography Predicts Hematoma Expansion in Intracerebral Hemorrhage
Neurol 68:889-894, Goldstein,J.N.,et al, 2007

Improvement of Gait by Chronic, High Doses of Methylphenidate in Patients with Advanced Parkinsons Disease
JNNP 78:470-475, Devos,D.,et al, 2007

Pathological Gambling after Bilateral Subthalamic Nucleus Stimulation in Parkinson Disease
JNNP 78:517-519, Smeding,H.M.M.,et al, 2007

Insomnia in Parkinsons Disease:Frequency and Progression Over Time
JNNP 78:476-479, Gjerstad,M.D.,et al, 2007

Individual Dopaminergic Neurons Show Raised Iron Levels in Parkinson Disease
Neurol 68:1820-1825, Oakley,A.E.,et al, 2007

Early Care Limitations Independently Predict Mortality After Intracerebral Hemorrhage
Neurol 68:1651-1657,1647, Zahuranec,D.B.,et al, 2007

Transdermal Rotigotine: Double-Blind, Placebo-Controlled Trial in Parkinson Disease
Arch Neurol 64:676-682, Jankovic,J.,et al, 2007

Parkinsons Disease and Driving Ability
JNNP 78:363-366, Singh,R.,et al, 2007

Advanced Parkinson Disease Treated with Rotigotine Transdermal System PREFER Study
Neurol 68:1262-1267, LeWitt,P.A.,et al, 2007

Clinical Update:Diagnosis and Treatment of Essential Tremor
Lancet 369:1152-1154, Benito-Leon,J&Louis,E.D., 2007

Wilson Disease: Description of 282 Patients Evaluated Over 3 Decades
Medicine 86:112-121, Taly,A.B., et al, 2007

Paraneoplastic Vasculitis of Central Nervous System Presenting as Recurrent Cryptogenic Stroke
Int J Clin Oncol 12:155-159, Taccone,F.S.,et al, 2007

Wolff-Parkinson-White Syndrome in Patients with MELAS
Arch Neurol 64:1625-1627, Sproule,D.M.,et al, 2007

Lyme Neuroborreliosis Presenting as the Syndrome of Inappropriate Antidiutetic Hormone Secretion
MedGenMed 8:71, Perkins, M.P.,et al, 2006

The Pull Test:A History
Mov Disord 21:894-899, Hunt,A.L.,et al, 2006

Vascular Parkinsonism and Dementia in a CADASIL Case with Intact Nigrostriatal Dopaminergic System
Akt Neurol 33: Suppl, Wegner,F.,et al, 2006

Suicide After Deep Brain Stimulation of the Internal Globus Pallidus for Dystonia
Neurol 66:142-143, Foncke,E.M.J.,et al, 2006

Panic and Fear Induced by Deep Brain Stimulation
JNNP 77:410-412, Shapira,HN.A.,et al, 2006

Presentation of Intracerebral Haemorrhage in a Community
JNNP 77:340-344, Zahuranec,D.B.,et al, 2006

Silent Microbleeds Are Associated with Volume of Primary Intracerebral Hemorrhage
Neurol 66:430-432, Lee,S-H.,et al, 2006

Hiccups Associated with Dopamine Agonists in Parkinson Disease
Neurol 66:774-775, Sharma,P.,et al, 2006

Benign Tremulous Parkinsonism
Arch Neurol 63:354-357,321, Josephs,K.A.,et al, 2006

What is the Risk of Developing Parkinsonism Following Neuroleptic Use?
Neurol 66:941-943, Noyes,K.,et al, 2006

Nonsteroidal Anti-Inflammatory Drugs and the Incidence of Parkinson Disease
Neurol 66:1097-1099, Hernan,M.A.,et al, 2006

Practice Parameter: Evaluation and Treatment of Depression, Psychosis, and Dementia in Parkinson Disease (An Evidence-Based Review)
Neurol 66:996-1002, Miyasaki,J.M.,et al, 2006

Practice Parameter: Treatment of Parkinson Disease with Motor Fluctuations and Dyskinesia (An Evidence-Based Review)
Neurol 66:983-995, Pahwa,R.,et al, 2006

The Parkinsons Complex: Parkinsonism Is Just the Tip of the Iceberg
Ann Neurol 59:591-596, Langston,J.W., 2006

Practice Parameter: Neuroprotective Strategies and Alternative Therapies for Parkinson Disease (An Evidence-Based Review)
Neurol 66:976-982, Suchowersky,O.,et al, 2006

Antiplatelets, ACE Inhibitors, and Statins Combination Reduces Stroke Severity and Tissue At Risk
Neurol 66:1153-1158, Kumar,S.,et al, 2006

Hematoma Growth is a Determinant of Mortality and Poor Outcome After Intracerebral Hemorrhage
Neurol 66:1175-1181, Davis,S.M.,et al, 2006

Safety of Rasagiline in Elderly Patients with Parkinson Disease
Neurol 66:1427-1429, Goetz,C.G.,et al, 2006

Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases
JAMA 295:2483-2491,2535, Aoyama,H.,et al, 2006

Prospective Prevalence of Pathologic Gambling and Medication Association in Parkinson Disease
Neurol 66:1750-1752, Voon,V.,et al, 2006

Showing articles 650 to 700 of 2059 << Previous Next >>